Close
Achema middle east
swop processing & packaging

ULURU unveils Altrazeal 0.75gm blister pack in US

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Amcor to showcase responsible and patient-centric packaging innovations at CPHI Frankfurt 2025

User-friendly solutions designed to enhance convenience, performance and patient...

Optimizing Pharma Packaging for Shipping & Distribution Resilience

Building Robust Supply Chain Networks Through Strategic Packaging Design The...

Pharma Packaging Traceability: Drug to Patient Compliance Tool

Traceability from Drug to Patient: Packaging as a Compliance...

End-of-Line Pharma Packaging Trends in Automated Palletizing

End-of-Line Pharma Packaging: Trends in Automated Palletizing & Depalletizing Transforming...

Specialty pharmaceutical company ULURU has introduced Altrazeal in a 0.75gm blister pack targeting US chronic wound market.

New packaging system provides information regarding appropriate quantity for the treatment of chronic wounds and contains an applicator for easy usage.

The transparent blister pack allows the physician to see the product during application and reduces wastage in addition to displaying unit cost for the treatment of small chronic wounds.

ULURU president and CEO Kerry Gray said the volume of product and the associated treatment cost is more appropriate for smaller chronic wounds in the new blister pack.

“Currently, the cost of the dressing used in a wound care center is covered under a procedural code, consequently, these facilities are very cost conscious when choosing the wound dressing to be used,” Gray added.

“The blister pack concept is a significant advancement in the delivery of Altrazeal to the wound and provides a product enhancement requested by wound care professionals.”

Altrazeal, an advanced scientifically engineered material, established potential clinical and economic advantages in various chronic and acute wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers and geriatric wounds.

Company continues offering Altrazeal in 2gm and 5gm foil pouches.

Latest stories

Related stories

Amcor to showcase responsible and patient-centric packaging innovations at CPHI Frankfurt 2025

User-friendly solutions designed to enhance convenience, performance and patient...

Optimizing Pharma Packaging for Shipping & Distribution Resilience

Building Robust Supply Chain Networks Through Strategic Packaging Design The...

Pharma Packaging Traceability: Drug to Patient Compliance Tool

Traceability from Drug to Patient: Packaging as a Compliance...

End-of-Line Pharma Packaging Trends in Automated Palletizing

End-of-Line Pharma Packaging: Trends in Automated Palletizing & Depalletizing Transforming...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »